![Victor Sandor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Victor Sandor
Directeur/Membre du Conseil chez
ADC THERAPEUTICS SA
Fortune : 478 332 $ au 31/05/2026
Profil
Dr. Victor Sandor, MD, is an Independent Director at AbCellera Biologics, Inc., an Independent Director at Kymera Therapeutics, Inc., an Independent Director at Prelude Therapeutics, Inc. and an Independent Non-Executive Director at ADC Therapeutics SA. He is on the Board of Directors at AbCellera Biologics, Inc., Kymera Therapeutics, Inc., Prelude Therapeutics, Inc., ADC Therapeutics SA and Istari Oncology, Inc. Dr. Sandor was previously employed as an Independent Non-Executive Director by Merus NV, a Chief Medical Officer by Array BioPharma, Inc., a Chief Medical Officer-Oncology & VP by Biogen Idec, Inc. (North Carolina), a Senior VP-Drug Development by Incyte Corp., and a Head-Oncology Product Development by AstraZeneca, Inc. He received his doctorate degree from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 0,11 % | 03/06/2026 | 140 686 ( 0,11 % ) | 478 332 $ | 31/05/2026 |
| 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Victor Sandor
| Sociétés | Poste | Début |
|---|---|---|
| ADC THERAPEUTICS SA | Directeur/Membre du Conseil | 27/04/2020 |
| PRELUDE THERAPEUTICS INCORPORATED | Directeur/Membre du Conseil | 01/05/2020 |
| KYMERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/11/2022 |
| ABCELLERA BIOLOGICS INC. | Directeur/Membre du Conseil | 01/06/2026 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Directeur/Membre du Conseil | 01/07/2019 |
Anciens postes connus de Victor Sandor
| Sociétés | Poste | Fin |
|---|---|---|
| MERUS N.V. | Directeur/Membre du Conseil | 12/12/2025 |
| INCYTE CORPORATION | Directeur Technique/Scientifique/R&D | 01/09/2019 |
| ARRAY TECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | 01/08/2019 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/09/2014 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Victor Sandor
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
